Share on StockTwits

GTx (NASDAQ:GTXI) VP James T. Dalton unloaded 72,883 shares of the stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $1.30, for a total transaction of $94,747.90. The sale was disclosed in a document filed with the SEC, which is available at this link.

Shares of GTx (NASDAQ:GTXI) traded up 2.31% during mid-day trading on Monday, hitting $1.33. 226,367 shares of the company’s stock traded hands. GTx has a one year low of $1.26 and a one year high of $7.24. The stock has a 50-day moving average of $1.42 and a 200-day moving average of $1.62. The company’s market cap is $100.0 million.

GTx (NASDAQ:GTXI) last released its earnings data on Thursday, May 8th. The company reported ($0.14) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.12) by $0.02. During the same quarter in the previous year, the company posted ($0.20) earnings per share. On average, analysts predict that GTx will post $-0.45 earnings per share for the current fiscal year.

GTx, Inc is a biopharmaceutical company. The Company is developing selective androgen receptor modulators (NASDAQ:GTXI) , a drugs with the potential to prevents and treat muscle wasting in patients with cancer and other musculoskeletal wasting or muscle loss conditions, including chronic sarcopenia (age related muscle loss).

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.